Silverback Therapeutics logo
Silverback Therapeutics SBTX
$ 6.1 4.99%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Silverback Therapeutics Long Term Debt 2011-2024 | SBTX

Annual Long Term Debt Silverback Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
37 K 251 K 480 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
480 K 37 K 256 K

Quarterly Long Term Debt Silverback Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - 37 K 92 K 146 K 199 K 251 K - 4.06 M 4.43 M 4.76 M 5.08 M 1.78 M 2.06 M 2.33 M 2.33 M 2.33 M 2.33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
5.08 M 37 K 2.15 M